169 related articles for article (PubMed ID: 8580019)
1. von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura.
De Mattia D; Penza R; Giordano P; Del Vecchio GC; Aceto G; Altomare M; Schettini F
Pediatr Nephrol; 1995 Oct; 9(5):603-5. PubMed ID: 8580019
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Schönlein purpura. Japanese Pediatric Group.
Fukui H; Kamitsuji H; Nagao T; Yamada K; Akatsuka J; Inagaki M; Shike S; Kobayashi Y; Yoshioka K; Maki S
Thromb Res; 1989 Dec; 56(6):667-75. PubMed ID: 2699100
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of blood coagulation factor XIII activity in adult Henoch-Schönlein purpura.
Matayoshi T; Omi T; Sakai N; Kawana S
J Nippon Med Sch; 2013; 80(4):268-78. PubMed ID: 23995569
[TBL] [Abstract][Full Text] [Related]
4. Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch-Schönlein purpura. Efficacy of factor XIII substitution.
Kamitsuji H; Tani K; Yasui M; Taniguchi A; Taira K; Tsukada S; Iida Y; Kanki H; Fukui H
Eur J Pediatr; 1987 Sep; 146(5):519-23. PubMed ID: 3678279
[TBL] [Abstract][Full Text] [Related]
5. [The prognostic value of factor XIII in Schönlein-Henoch purpura in childhood (author's transl)].
Dalens B; Bezou MJ; Goumy P; Déméocq F; Menut G
Arch Fr Pediatr; 1980 Feb; 37(2):99-101. PubMed ID: 7396652
[TBL] [Abstract][Full Text] [Related]
6. Henoch-Schönlein purpura in a child with Guillain-Barré syndrome.
Fuchigami T; Hasegawa M; Hashimoto K; Fujita Y; Inamo Y
Pediatr Neurol; 2010 Dec; 43(6):431-4. PubMed ID: 21093736
[TBL] [Abstract][Full Text] [Related]
7. Cytokine pattern and endothelium damage markers in Henoch-Schönlein purpura.
Del Vecchio GC; Penza R; Altomare M; Piacente L; Aceto G; Lassandro G; De Mattia D; Giordano P
Immunopharmacol Immunotoxicol; 2008; 30(3):623-9. PubMed ID: 18668398
[TBL] [Abstract][Full Text] [Related]
8. Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura.
Casonato A; Pontara E; Bertomoro A; Ossi E; Vincenti M; Girolami A; Borsatti A; Bertaglia G
Am J Hematol; 1996 Jan; 51(1):7-11. PubMed ID: 8571941
[TBL] [Abstract][Full Text] [Related]
9. Association between anti-α-1,4-D-polygalacturonic acid antibodies and Henoch-Schönlein purpura in children.
Miao M; Li X; Wang Q; Zhu Y; Cui Y; Shao X
J Int Med Res; 2019 Jun; 47(6):2545-2554. PubMed ID: 31068035
[TBL] [Abstract][Full Text] [Related]
10. The elevated markers of hypercoagulability in children with Henoch-Schönlein purpura.
Yilmaz D; Kavakli K; Ozkayin N
Pediatr Hematol Oncol; 2005; 22(1):41-8. PubMed ID: 15770830
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis].
Ru L; Abudouhaer A; Guo YF
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):1009-13. PubMed ID: 24229600
[TBL] [Abstract][Full Text] [Related]
12. [Behavior of coagulation parameters in the Schönlein-Henoch syndrome. Diagnostic value of factor XIII].
Barberio G; Manganaro R; Ruggeri C; Cambria R; Gattarello A; Gemelli M
Minerva Pediatr; 1981 Aug; 33(16):817-20. PubMed ID: 7311944
[No Abstract] [Full Text] [Related]
13. Circulating adhesion molecules ICAM-1, E-selectin, and von Willebrand factor in Henoch-Schönlein purpura.
Söylemezoglu O; Sultan N; Gursel T; Buyan N; Hasanoglu E
Arch Dis Child; 1996 Dec; 75(6):507-11. PubMed ID: 9014604
[TBL] [Abstract][Full Text] [Related]
14. Sequential measurements of the reticulo-endothelial system function in Henoch-Schönlein disease of childhood. Correlations with various immunological parameters.
Davin JC; Vandenbroeck MC; Foidart JB; Mahieu PR
Acta Paediatr Scand; 1985 Mar; 74(2):201-6. PubMed ID: 3993366
[TBL] [Abstract][Full Text] [Related]
15. IgA anticardiolipin antibodies associated with Henoch-Schönlein purpura.
Burden AD; Gibson IW; Rodger RS; Tillman DM
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 2):857-60. PubMed ID: 7962736
[TBL] [Abstract][Full Text] [Related]
16. The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-alpha treatment in children with Henoch-Schönlein purpura.
Yang YH; Wang SJ; Chuang YH; Lin YT; Chiang BL
Clin Exp Immunol; 2002 Nov; 130(2):352-7. PubMed ID: 12390327
[TBL] [Abstract][Full Text] [Related]
17. Decreased factor XIII activity during severe Henoch-Schoenlein purpura -- does it play a role?
Prenzel F; Pfäffle R; Thiele F; Schuster V
Klin Padiatr; 2006; 218(3):174-6. PubMed ID: 16688675
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of the serum biomarker index detection in children with Henoch-Schonlein purpura.
Purevdorj N; Mu Y; Gu Y; Zheng F; Wang R; Yu J; Sun X
Clin Biochem; 2018 Feb; 52():167-170. PubMed ID: 29129626
[TBL] [Abstract][Full Text] [Related]
19. Properties of circulating IgA molecules in Henoch-Schönlein purpura nephritis with focus on neutrophil cytoplasmic antigen IgA binding (IgA-ANCA): new insight into a debated issue. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura in adults and in children.
Coppo R; Cirina P; Amore A; Sinico RA; Radice A; Rollino C
Nephrol Dial Transplant; 1997 Nov; 12(11):2269-76. PubMed ID: 9394310
[TBL] [Abstract][Full Text] [Related]
20. Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors.
Kaku Y; Nohara K; Honda S
Kidney Int; 1998 Jun; 53(6):1755-9. PubMed ID: 9607209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
